BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 10, 2025
Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

NexMed Raises $10.5M Through Private Sale Of Common Shares

July 8, 2003
By Aaron Lorenzo

Endo's Largest Shareholder Selling Stock Worth $232.5M

July 3, 2003
By Aaron Lorenzo

Gilead's Antiretroviral Emtriva Receives FDA Approval In HIV

July 3, 2003
By Aaron Lorenzo
HIV patients gained another treatment option yesterday as the FDA signed off on Emtriva, a once-daily capsule for HIV from Gilead Sciences Inc. (BioWorld Today)
Read More

Endo's Largest Shareholder Selling Stock Worth $232.5M

July 3, 2003
By Aaron Lorenzo

Gilead's Antiretroviral Emtriva Receives FDA Approval In HIV

July 3, 2003
By Aaron Lorenzo
HIV patients gained another treatment option yesterday as the FDA signed off on Emtriva, a once-daily capsule for HIV from Gilead Sciences Inc. (BioWorld Today)
Read More

Vivus' PDE5 Inhibitor Fails In Premature Ejaculation Study

July 2, 2003
By Aaron Lorenzo

Vivus' PDE5 Inhibitor Fails In Premature Ejaculation Study

July 2, 2003
By Aaron Lorenzo

Pain Therapeutics Ready To Start Pivotal Phase III Study Of Oxytrex

July 1, 2003
By Aaron Lorenzo

Pain Therapeutics Ready To Start Pivotal Phase III Study Of Oxytrex

July 1, 2003
By Aaron Lorenzo

GSK Spin-Off Affymax Generates $20M In Private Financing Round

June 30, 2003
By Aaron Lorenzo
Affymax Inc. closed a $20 million private round of financing that coincided with the drug discovery and development firm's appointment of a new chief executive. (BioWorld Today)
Read More
View All Articles by Aaron Lorenzo

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 9, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • NME Digest: Q1 2025

    BioWorld
    A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing